Cover Image
市場調查報告書

腦脊髓液管理:開發平台分析

Cerebrospinal Fluid Management - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 340315
出版日期 內容資訊 英文 94 Pages
訂單完成後即時交付
價格
Back to Top
腦脊髓液管理:開發平台分析 Cerebrospinal Fluid Management - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月01日 內容資訊: 英文 94 Pages
簡介

本報告提供腦脊髓液管理相關開發平台上各種處於開發階段之產品綜合分析,並彙整關乎產品開發的主要企業之評估,臨床實驗趨勢等開發平台概要與臨床實驗資料等資訊。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 各開發階段平台
  • 各市場區隔開發平台
  • 各領域開發平台
  • 各法律途徑開發平台
  • 認證預定日別開發平台
  • 進行中的臨床實驗趨勢

第4章 各企業正在開發的開發中產品

  • 腦髓液管理企業:各開發階段平台產品
  • 腦髓液管理:各開發階段平台產品

第5章 企業及產品概要

  • Aqueduct Neurosciences
  • Arkis BioSciences
  • Beckersmith Medical, Inc.
  • Biosan Medical Ltd.
  • Ceremed, Inc.
  • CSF Therapeutics, Inc.
  • Georgia Institute of Technology
  • H-Cubed Inc.
  • Integra LifeSciences Holdings Corporation
  • InVivo Therapeutics Corporation
  • Kerecis ehf
  • Microbot Medical, Ltd.
  • Nanonerve Inc.
  • NexGen Medical Systems, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • System Science Inc.
  • University Hospital Zurich
  • University of Colorado
  • University of Rochester
  • University of South Florida
  • University of Wisconsin Madison
  • Vivonics, Inc.
  • Wayne State University

第6章 近幾年趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0426EPD

GlobalData's Medical Devices sector report, "Cerebrospinal Fluid Management - Medical Devices Pipeline Assessment, 2017" provides an overview of Cerebrospinal Fluid Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebrospinal Fluid Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cerebrospinal Fluid Management under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cerebrospinal Fluid Management and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cerebrospinal Fluid Management under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Cerebrospinal Fluid Management Overview 8

3 Products under Development 9

  • 3.1 Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 9
  • 3.2 Cerebrospinal Fluid Management - Pipeline Products by Segment 10
  • 3.3 Cerebrospinal Fluid Management - Pipeline Products by Territory 11
  • 3.4 Cerebrospinal Fluid Management - Pipeline Products by Regulatory Path 12
  • 3.5 Cerebrospinal Fluid Management - Pipeline Products by Estimated Approval Date 13
  • 3.6 Cerebrospinal Fluid Management - Ongoing Clinical Trials 14

4 Cerebrospinal Fluid Management - Pipeline Products under Development by Companies 15

  • 4.1 Cerebrospinal Fluid Management Companies - Pipeline Products by Stage of Development 15
  • 4.2 Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 17

5 Cerebrospinal Fluid Management Companies and Product Overview 18

  • 5.1 Alcyone Lifesciences Inc Company Overview 18
    • 5.1.1 Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Aqueduct Neurosciences Company Overview 21
    • 5.2.1 Aqueduct Neurosciences Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Arkis BioSciences Company Overview 22
    • 5.3.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Beckersmith Medical, Inc. Company Overview 23
    • 5.4.1 Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 Biosan Medical Ltd. Company Overview 24
    • 5.5.1 Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.6 CereVasc LLC Company Overview 25
    • 5.6.1 CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.7 Georgia Institute of Technology Company Overview 26
    • 5.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.8 H-Cubed Inc. Company Overview 27
    • 5.8.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.9 Integra LifeSciences Holdings Corp Company Overview 28
    • 5.9.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.10 InVivo Therapeutics Corp Company Overview 30
    • 5.10.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.11 Kerecis ehf Company Overview 33
    • 5.11.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.12 Kuros Biosciences AG Company Overview 34
    • 5.12.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.13 Microbot Medical Ltd Company Overview 35
    • 5.13.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.14 Monitor Med Solutions Company Overview 38
    • 5.14.1 Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.15 Nanonerve Inc. Company Overview 39
    • 5.15.1 Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.16 NeuraMedica, LLC Company Overview 40
    • 5.16.1 NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.17 NexGen Medical Systems Inc Company Overview 41
    • 5.17.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.18 Nurami Medical Ltd Company Overview 42
    • 5.18.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 43
    • 5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.20 System Science Inc. Company Overview 45
    • 5.20.1 System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.21 University Hospital Zurich Company Overview 47
    • 5.21.1 University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.22 University of Rochester Company Overview 48
    • 5.22.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.23 University of South Florida Company Overview 49
    • 5.23.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.24 University of Wisconsin Madison Company Overview 51
    • 5.24.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.25 Vivonics, Inc. Company Overview 53
    • 5.25.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.26 Wayne State University Company Overview 54
    • 5.26.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 54

6 Cerebrospinal Fluid Management Management- Recent Developments 55

  • 6.1 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 55
  • 6.2 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 57
  • 6.3 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 57
  • 6.4 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 58
  • 6.5 Jul 10, 2017: InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer 59
  • 6.6 Jun 21, 2017: Kuros receives CE certification for Neuroseal, a novel dural sealant 60
  • 6.7 Jun 14, 2017: Microbot Medical Continues to Solidify IP Portfolio with US Patent for Previously Disclosed Device for Preventing Shunt Stenosis 61
  • 6.8 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 61
  • 6.9 May 31, 2017: Microbot Medical Announces Issuance Of A Canadian Patent Covering A Self-Cleaning Shunt 62
  • 6.10 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 62
  • 6.11 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 64
  • 6.12 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 67
  • 6.13 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 67
  • 6.14 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 68
  • 6.15 Apr 06, 2017: Medtronic Announces Voluntary Worldwide Recall Of Its StrataMR Adjustable Valves And Shunts 69
  • 6.16 Mar 31, 2017: B. Braun continues its sales and earnings growth 69
  • 6.17 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 71
  • 6.18 Mar 07, 2017: TGA Announces Hazard Alert for Medtronic StrataMR Adjustable Valves and Shunts 72
  • 6.19 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 72
  • 6.20 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 73
  • 6.21 Feb 22, 2017: Microbot Medical Inc. Announces Significant Technology Patent Allowance in the U.S. 75
  • 6.22 Feb 22, 2017: Change in the B. Braun Management Board 75
  • 6.23 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 75
  • 6.24 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 78
  • 6.25 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 79
  • 6.26 Dec 21, 2016: Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant 79
  • 6.27 Dec 05, 2016: Integra LifeSciences announces management changes 80
  • 6.28 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 80
  • 6.29 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 81
  • 6.30 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 84
  • 6.31 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 84
  • 6.32 Nov 14, 2016: HyperBranch Medical Technology Launches Innovative Adherus AutoSpray Extended Tip (ET) Dural Sealant for Cranial Neurosurgery 85
  • 6.33 Nov 04, 2016: InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update 86
  • 6.34 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 87
  • 6.35 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 88
  • 6.36 Oct 12, 2016: HyperBranch Medical Wins Decision Against Integra Lifesciences 88
  • 6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 89

7 Appendix 91

  • 7.1 Methodology 91
  • 7.2 About GlobalData 94
  • 7.3 Contact Us 94
  • 7.4 Disclaimer 94

List of Tables

1.1 List of Tables

  • Table 1: Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 9
  • Table 2: Cerebrospinal Fluid Management - Pipeline Products by Segment 10
  • Table 3: Cerebrospinal Fluid Management - Pipeline Products by Territory 11
  • Table 4: Cerebrospinal Fluid Management - Pipeline Products by Regulatory Path 12
  • Table 5: Cerebrospinal Fluid Management - Pipeline Products by Estimated Approval Date 13
  • Table 6: Cerebrospinal Fluid Management - Ongoing Clinical Trials 14
  • Table 7: CSF Management Companies - Pipeline Products by Stage of Development 15
  • Table 8: Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 17
  • Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 10: ReFlow Ventricular System - Product Status 18
  • Table 11: ReFlow Ventricular System - Product Description 18
  • Table 12: Alcyone Lifesciences Inc - Ongoing Clinical Trials Overview 19
  • Table 13: ReFlow Ventricular System - Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters 20
  • Table 14: Aqueduct Neurosciences Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 15: Smart Shunt - Product Status 21
  • Table 16: Smart Shunt - Product Description 21
  • Table 17: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 18: Arkis AutoShunt - Product Status 22
  • Table 19: Arkis AutoShunt - Product Description 22
  • Table 20: Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 21: FlowSafe - Product Status 23
  • Table 22: FlowSafe - Product Description 23
  • Table 23: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 24: Ventritek105 - Product Status 24
  • Table 25: Ventritek105 - Product Description 24
  • Table 26: CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 27: eShunt - Product Status 25
  • Table 28: eShunt - Product Description 25
  • Table 29: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 30: Hydrocephalus Shunt - Product Status 26
  • Table 31: Hydrocephalus Shunt - Product Description 26
  • Table 32: H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 33: Ambulatory System For Hydrocephalus Shunt - Product Status 27
  • Table 34: Ambulatory System For Hydrocephalus Shunt - Product Description 27
  • Table 35: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 36: Hydrocephalic Shunt - Product Status 28
  • Table 37: Hydrocephalic Shunt - Product Description 28
  • Table 38: Next Generation DuraSeal - Product Status 29
  • Table 39: Next Generation DuraSeal - Product Description 29
  • Table 40: Ventricular Drainage Device - Product Status 29
  • Table 41: Ventricular Drainage Device - Product Description 29
  • Table 42: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 43: Dural Graft - Product Status 30
  • Table 44: Dural Graft - Product Description 30
  • Table 45: InVivo Therapeutics Corp - Ongoing Clinical Trials Overview 31
  • Table 46: Dural Graft - A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Grafting (CABG) 32
  • Table 47: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 48: Kerecis Omega3 Dura - Product Status 33
  • Table 49: Kerecis Omega3 Dura - Product Description 33
  • Table 50: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 51: Neuroseal - Cranial - Product Status 34
  • Table 52: Neuroseal - Cranial - Product Description 34
  • Table 53: Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 54: Self-Cleaning Shunt (SCS) Device - Product Status 35
  • Table 55: Self-Cleaning Shunt (SCS) Device - Product Description 35
  • Table 56: Microbot Medical Ltd - Ongoing Clinical Trials Overview 36
  • Table 57: Self-Cleaning Shunt (SCS) Device - Clinical Investigation of Self-Cleaning Shunt (SCS) Device 37
  • Table 58: Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 59: Hydrocephalus Shunt System - Product Status 38
  • Table 60: Hydrocephalus Shunt System - Product Description 38
  • Table 61: Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 62: Nanofibrous Dural Substitute - Product Status 39
  • Table 63: Nanofibrous Dural Substitute - Product Description 39
  • Table 64: NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 65: Dural Clip - Product Status 40
  • Table 66: Dural Clip - Product Description 40
  • Table 67: NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 68: EViTAR FLOWMETER - Product Status 41
  • Table 69: EViTAR FLOWMETER - Product Description 41
  • Table 70: Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 71: Dural Substitute Patch - Product Status 42
  • Table 72: Dural Substitute Patch - Product Description 42
  • Table 73: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 74: Bovine Pericardium - Dura Substitute - Product Status 43
  • Table 75: Bovine Pericardium - Dura Substitute - Product Description 43
  • Table 76: Programmable Hydrocephalus Stent - Product Status 44
  • Table 77: Programmable Hydrocephalus Stent - Product Description 44
  • Table 78: System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 79: Acute Cerebrospinal Fluid Monitor And Control System - Product Status 45
  • Table 80: Acute Cerebrospinal Fluid Monitor And Control System - Product Description 45
  • Table 81: Implantable Cerebrospinal Fluid Monitor And Control System - Product Status 46
  • Table 82: Implantable Cerebrospinal Fluid Monitor And Control System - Product Description 46
  • Table 83: University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 84: SmartShunt - Product Status 47
  • Table 85: SmartShunt - Product Description 47
  • Table 86: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 87: Catheterless Shunt System - Product Status 48
  • Table 88: Catheterless Shunt System - Product Description 48
  • Table 89: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 90: Shunt Catheter System With Inline Filter - Product Status 49
  • Table 91: Shunt Catheter System With Inline Filter - Product Description 49
  • Table 92: Sonic Window Cranioplasty Implant - Product Status 50
  • Table 93: Sonic Window Cranioplasty Implant - Product Description 50
  • Table 94: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 95: Gravity And Pressure Controlled Valve System - Product Status 51
  • Table 96: Gravity And Pressure Controlled Valve System - Product Description 51
  • Table 97: Hydrocephalus Stent - Product Status 52
  • Table 98: Hydrocephalus Stent - Product Description 52
  • Table 99: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 100: Shunt Flowmeter - Product Status 53
  • Table 101: Shunt Flowmeter - Product Description 53
  • Table 102: Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 103: Programmable Antisiphon Shunt System - Product Status 54
  • Table 104: Programmable Antisiphon Shunt System - Product Description 54
  • Table 105: Glossary 93

List of Figures

1.2 List of Figures

  • Figure 1: Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 9
  • Figure 2: Cerebrospinal Fluid Management - Pipeline Products by Segment 10
  • Figure 3: Cerebrospinal Fluid Management - Pipeline Products by Territory 11
  • Figure 4: Cerebrospinal Fluid Management - Pipeline Products by Regulatory Path 12
  • Figure 5: Cerebrospinal Fluid Management - Pipeline Products by Estimated Approval Date 13
  • Figure 6: Cerebrospinal Fluid Management - Ongoing Clinical Trials 14
Back to Top